InstaRX — NAD+ route, dose and price
InstaRX is not a partner — this company pays us nothing, and it is listed anyway.
InstaRX publishes a floor only for NAD+, across 1 distinct figure read from its own page.
1 figure, by route
| Route | Dose | Price |
|---|---|---|
| Route not stated | dose not stated | $265/Month |
advertised floor for something the seller does not name The asterisk in the headline resolves to a footnote further down the same page: '*For 12 month prepayment' — recorded verbatim here rather than classified. The page calls the product an 'NAD+ Injection' but never names a route (no 'subcutaneous', no 'IV', no clinic/at-home administration statement), so route is left unspecified. ⚠ The descriptive paragraph directly under this heading describes tirzepatide, not NAD+ — see pageNotes; the figure may be inherited boilerplate.
| ||
We are paid nothing if you sign up here.
What else the page states
- Routes this seller names
- None. Every figure on this seller's page carries no route at all — the seller's own silence, not a gap in the data.
- Where the link goes
- Straight to this company's own NAD+ page.
Where InstaRX sits
On the full roster it is row 35 of 106. That roster is ordered by what each seller states about its own figures and by nothing else — payment changes neither a price recorded here nor where a row sits.
We are paid nothing if you sign up here.
Prices move. Everything above was read on September 2026 and is republished with that date attached; check InstaRX’s own page before you buy.